CANF

CANF Retained Earnings

-$180.79MQuarterly · USD

Period ending:

CANF FY Retained EarningsUSD
CANF FY Retained Earnings2011-12-31: -$60.85M2012-12-31: -$67.28M2013-12-31: -$80.51M2014-12-31: -$78.11M2015-12-31: -$82.71M2016-12-31: -$90.98M2017-12-31: -$105.66M2018-12-31: -$100.62M2019-12-31: -$110.31M2020-12-31: -$125.47M2021-12-31: -$140.67M2022-12-31: -$150.85M2023-12-31: -$158.48M2024-12-31: -$166.36M2025-12-31: -$176.19M$0.00-$176.19M
2011-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CANF retained earnings history

Cumulative earnings retained in the business. The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares Retained Earnings — Annual fiscal periods (USD)
Period endingRetained Earnings (USD)
-176,186,268
-166,361,000
-158,481,000
-150,847,000
-140,674,000
-125,469,000
-110,311,000
-100,623,000
-105,657,153
-90,977,227
-82,711,097
-78,108,749
-80,514,286
-67,281,327
-60,847,084

Compare retained earnings

All CANF financial metrics · CANF stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.